{
    "organizations": [],
    "uuid": "5a2391faeec0f984edc63b1efccceb00caddbf6c",
    "author": "",
    "url": "https://www.reuters.com/article/brief-cas-group-announces-glass-lewis-re/brief-cas-group-announces-glass-lewis-recommendation-that-aviragen-stockholders-vote-against-merger-idUSFWN1PQ16E",
    "ord_in_thread": 0,
    "title": "BRIEF-CAS Group Announces Glass Lewis Recommendation That Aviragen Stockholders Vote Against Merger",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Jan 31 (Reuters) - Aviragen Therapeutics Inc:\n* CAS GROUP ANNOUNCES GLASS LEWIS RECOMMENDATION THAT AVIRAGEN STOCKHOLDERS VOTE AGAINST MERGER AND EMPHASIZES VALUE OF TESLEXIVIR (BTA074) PROGRAM Source text for Eikon: Further company coverage:\n ",
    "published": "2018-01-31T16:16:00.000+02:00",
    "crawled": "2018-01-31T16:32:55.012+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "jan",
        "reuters",
        "aviragen",
        "therapeutic",
        "inc",
        "ca",
        "group",
        "announces",
        "glass",
        "lewis",
        "recommendation",
        "aviragen",
        "stockholder",
        "vote",
        "merger",
        "emphasizes",
        "value",
        "teslexivir",
        "bta074",
        "program",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}